#USA #Veeva Systems #Pleasanton #Vault CRM #Gilead Sciences

Gilead Sciences Chooses Veeva Vault CRM

In a significant move for the biopharmaceutical industry, Gilead Sciences, Inc. has announced its decision to partner with Veeva Systems for the implementation of the cutting-edge Vault CRM (Customer Relationship Management) system. This collaboration aims to bolster Gilead's capacity to bring groundbreaking medical advancements to patients across the globe.

Peter Gassner, the CEO of Veeva, expressed enthusiasm over the partnership, stating, "Gilead is a leading provider of life-changing medicines and has made critical scientific advancements in virology, inflammation, and oncology. We are honored to be a strategic partner to Gilead and to expand this partnership with Vault CRM." This strategic decision roots from Gilead's commitment to innovate and enhance their commercial processes further.

Gilead Sciences is renowned for its relentless pursuit of breakthrough therapies that tackle some of the most pressing health challenges today, including HIV, hepatitis, and various forms of cancer. The adoption of Vault CRM is anticipated to not only streamline Gilead's customer interactions but also optimize their commercial execution, thus ensuring that innovative therapies reach patients faster and more efficiently.

The Role of Vault CRM and Veeva AI

The Vault CRM is a comprehensive suite designed to facilitate commercial operations in the biopharmaceutical domain. Veeva's offering includes Veeva AI, which equips the CRM with multiple AI agents such as meeting scheduling, compliant free-text options, and voice controls, aimed at enhancing business efficiency and effectiveness.

Anna Åsberg, Gilead's Global IT leader, highlighted the significance of this partnership, stating, “We are excited to expand our longstanding partnership with Veeva by transitioning to Vault CRM. We are aligned in our commitment to medical advancement, and we look forward to exploring the potential of Veeva AI to elevate our commercial execution to the next level.”

The Innovation Pursuit

Gilead's focus on innovation aligns perfectly with Veeva's mission. Veeva has established itself as a leader in the life sciences sector by offering cloud-based solutions tailored to meet the unique needs of biopharmaceutical companies. Veeva has a strong customer base, servicing over 1,500 clients, including some of the largest names in the industry and emerging biotech firms.

Veeva's commitment to innovation, product quality, and customer success has set a benchmark in the industry. The transition to Vault CRM is indicative of Gilead's dedication to embracing advanced technology to unify and enhance their approach in critical healthcare areas. The integration of such technologies not only serves to optimize operational workflows but also contributes to superior patient outcomes.

Future-Ready Healthcare Solutions

As the healthcare landscape continues to evolve rapidly, the partnership between Gilead Sciences and Veeva is emblematic of the growing need for advanced technological solutions in biopharma. By leveraging Veeva's Vault CRM and AI capabilities, Gilead is well-positioned to navigate the complexities of modern healthcare challenges.

This collaboration marks a promising step forward, demonstrating how technology can revolutionize the way the biopharmaceutical industry operates. As Gilead implements Veeva Vault CRM, both companies look forward to transforming healthcare through innovative solutions that make a tangible difference in patients' lives.

For those interested in more information about Veeva Systems and its offerings, you can visit their official website at veeva.com. Gilead Sciences continues its mission to create a healthier world through groundbreaking research and technology, striving to develop innovative medicines that effectively combat life-threatening diseases worldwide.